Erythema dyschromicum perstans: The continuing enigma of Cinderella or ashy dermatosis

International Journal of Dermatology

Volumn 43, Issue 3, 2004, Pages 230-232

  Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; CONTRAST MEDIUM; DAPSONE;

ANTIINFLAMMATORY ACTIVITY; ASHY DERMATOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG EFFICACY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; LICHEN PLANUS; NOTE; ONSET AGE; PATHOGENESIS; SKIN DISEASE;

ERYTHEMA; HUMANS; PIGMENTATION DISORDERS;

EID: 1842539442     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02001.x     Document Type: Note

References (47)

1. Ramirez CO. Los cenicientos: Problema clinica. In: Memoria del Primer Congresso Centroamericano de Dermatologica, December 5-8, 1957, San Salvador, El Salvador: (publisher unidentified), 1957: 122-130.
2. Ramirez CO, Lopez Lino DG. Estado actual de la dermatosis cenicienta. Sinonimia-erytema dischromicum perstans. Med Cután Ibero Lat Am 1984; 12: 11-18.
3. Jablonska S. Ingestion of ammonium nitrate as a possible cause of erythema dyschromicum perstans (ashy dermatosis). Dermatologica (Basel) 1975; 150: 287-291.
4. Lambert WC, Schwartz RA, Hamilton GB. Erythema dyschromicum perstans. Cutis 1986; 37: 42-44.
5. Ramirez CO. The ashy dermatosis (erythema dyschromicum perstans): Epidemiological study and report of 139 cases. Cutis 1967; 3: 244-247.
6. Convit J, Kerdel-Vegas F, Rodríguez G. Erythema dyschromicum perstans: A hitherto undescribed skin disease. J Invest Dermatol 1961; 36: 457-462.
7. Vega ME, Waxtein L, Arenas R, et al. Ashy dermatosis versus lichen planus pigmentosus: A controversial matter. Int J Dermatol 1992; 31: 87-88.
8. Vega ME, Waxtein L, Arenas R, et al. Ashy dermatosis and lichen planus pigmentosus: A clinicopathologic study of 31 cases. Int J Dermatol 1992; 31: 90-94.
9. Lee SJ, Chung KY. Erythema dyschromicum perstans in early childhood. J Dermatol (Tokyo) 1999; 26: 119-121.
10. Holst R, Mobachen H. Erythema dyschromicum perstans (ashy dermatosis). Report of two cases from Scandinavia. Acta Derm Venereol (Stockh) 1974; 54: 69-72.
11. Palatsi R. Erythema dyschromicum perstans: A follow-up study from northern Finland. Dermatologica (Basel) 1977; 155: 40-44.
12. Bahadir S, Çobanoglu Ü, Çimit G, et al. Erythema dyschromicum perstans: Response to dapsone therapy. Int J Dermatol in press.
13. Piquero-Martín J, Pérez-Alfonzo A, Abrusci V, et al. Clinical trial with clofazimine on treating erythema dyschromicum perstans. Evaluation of cell mediated immunity. Int J Dermatol 1989; 28: 198-200.
14. Schwartz RA, Centurión SA. Erythema dyschromicum perstans. eMedicine Dermatology [journal serial online] 2001. Available at: http://author.emedicine.com/derm/topic132.htm.
15. Shirahama S, Yagi H, Takigawa M, et al. A case of ashy dermatosis with unilateral and band-like distribution. Acta Dermatol Kyoto 1994; 89: 15-17.
16. Gellin GA, Hilger R, Harris DR, et al. Society Transactions with Discussion. San Francisco Dermatological Society. January 11, 1974. Erythema dyschromicum perstans (ashy dermatosis). Arch Dermatol 1974; 110: 963.
17. Zenorola P, Bisceglia M, Lomuto M. Ashy dermatosis associated with cobalt allergy. Contact Dermatitis 1994; 31: 53-54.
18. Paradisi M, Mostaccioli S, Celano G, et al. Erithema dyschromicum perstans (ashy dermatosis): Presentazione di due casi. Pathologica 1993; 85: 533-541.
19. Ing EB, Buncic JH, Weiser BA, et al. Periorbital hyperpigmentation and erythema dyschromicum perstans. Can J Ophthalmol 1992; 27: 353-355.
20. Miyagawa S, Komatsu M, Okuchi T, et al. Erythema dyschromicum perstans. Immunopathologic studies. J Am Acad Dermatol 1989; 20: 882-886.
21. Stevenson JR, Miura M. Erythema dyschromicum perstans (ashy dermatosis). Arch Dermatol 1966; 94: 197-199.
22. Tschen JA, Tschen EA. Erythema dyschromicum perstans. J Am Acad Dermatol 1980; 2: 295-302.
23. Convit J, Piquero-Martín J, Perez RM. Erythema dyschromicum perstans. Int J Dermatol 1989; 28: 168-169.
24. Knox JM, Dodge BG, Freeman RG. Erythema dyschromicum perstans. Arch Dermatol 1968; 97: 262-270.
25. Kennedy B, Obermayer M, Epstein WL, et al. Discussion. Arch Dermatol 1968; 97: 270-272.
26. Henderson CD, Tschen JA, Schaefer DG. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans. Arch Dermatol 1988; 124: 1258-1260.
27. Kark EC, Litt JZ. Ashy dermatosis - a variant of lichen planus? Cutis 1980; 25: 631-633.
28. Soter NA, Wand C, Freedman RG. Ultrastructural pathology of erythema dyschromicum perstans. J Invest Dermatol 1969; 52: 155-162.
29. Berger RS, Hayes TJ, Dixon SL. Erythema dyschromicum perstans and lichen planus: Are they related? J Am Acad Dermatol 1989; 21: 438-442.
30. Mastroianni A, Celleno L, Frati C, et al. Studio clinico ed ultrastrutturale su di un caso di "eRythema dyschronicum perstans". Chronica Dermatol (Roma) 1995; 5: 693-701.
31. Penagos H, Jimenez V, Fallas V, et al. Chlorothalonil, a possible cause of erythema dyschromicum perstans (ashy dermatitis). Contact Dermatitis 1996; 35: 214-218.
32. Baranda L, Torres-Alvarez B, Cortes-Franco R, et al. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch Dermatol 1997; 133: 325-329.
33. Nelson MR, Lawrence AG, Straughton RCD, et al. Erythema dyschromicum perstans in an HIV antibody-positive man. Br J Dermatol 1992; 127: 658-659.
34. Naidorf KF, Cohen SR. Erythema dyschromicum perstans and lichen planus. Arch Dermatol 1982; 118: 683-685.
35. Bhutani LK, Bedi TR, Pandhi RK, et al. Lichen planus pigmentosus. Dermatologica (Basel) 1974; 149: 43-50.
36. Shima T. Lichen planus pigmentosum. Nipon Hifuka Gakkai Zasshi 1956; 66: 346-353.
37. Gougerot M. Lichen atypiques on invisibles pigmento gènes révélés par des pigmentations. Bull Soc Fr Dermatol Syphiligr 1935; 42: 791-794.
38. e communication). Bull Soc Fr Dermatol Syphiligr 1935; 42: 894-898.
39. Metin A, Çalka Ö, Ugras S. Lichen planopilaris coexisting with erythema dyschromicum perstans. Br J Dermatol 2001; 145: 522-523.
40. Mizukawa Y, Shiohara T. Fixed drug eruption presenting as erythema dyschromicum perstans: A flare without taking any medications. Dermatologica (Basel) 1998; 197: 383-385.
41. Jang KA, Choi JH, Sung KS, et al. Idiopathic eruptive macular pigmentation: Report of 10 cases. J Am Acad Dermatol 2001; 44: 351-353.
42. Dominguez-Soto L. Anthropologic dermatology. Mexico. In: Parish LC, Millikan LE, Amer M, et al., eds. Global Dermatology. Diagnosis and Management According to Geography, Climate, and Culture. New York: Springer-Verlag, 1994: 197-202.
43. Osswald SS, Proffer LH, Sartori CR. Erythema dyschromicum perstans: A case report and review. Cutis 2001; 68: 25-28.
44. Kontochristopoulos GJ, Aroni K, Anagnostopoulos G, et al. Erythema dyschromicum perstans and hepatitis C virus infection. Int J Dermatol 2001; 40: 346-348.
45. Rotoli M, Stefanato CM, Rezza E. Erythema dyschromicum perstans-ashy dermatosis (EDP-AD). Giorn Ital Dermatol Venereol 1987; 122: 119-120.
46. Combemale P, Faisant M, Guennoc B, et al. Erythema dyschromicum perstans: Report of a new case and critical review of the literature. J Dermatol 1998; 25: 747-753.
47. Kontochristopoulos G, Stavropoulos P, Panteleos D, et al. Erythema dyschromicum perstans: Response to dapsone therapy. Int J Dermatol 1998; 37: 796-798.